RIBOZYME AND OMICS
PLATFORM TECHNOLOGY
Patent & Publication
Intellectual Property (cont.)
| No. | Country | Appl. Date | Appl. No. | Title | Patent No |
|---|---|---|---|---|---|
| 6 | KR | 2020-02-20 | 10-2020-0021014 | TUMOR-TARGETING TRANS-SPLICING RIBOZYME AND USE THEREOF | 10-2252423 |
| US | 2020-02-21 | 16/797,663 | 11,078,487 | ||
| EP | 2020-02-21 | 20158701.1 | |||
| JP | 2020-02-21 | 2020-28556 | |||
| CN | 2020-02-21 | 202010107272.7 | |||
| 7 | KR | 2014-12-22 | 10-2014-0185976 | CANCER SPECIFIC-SPLICING RIBOZYME AND USE THEREOF | 10-1712247 |
| JP | 2017-04-17 | 2017-518146 | 6633626 | ||
| EP | 2017-04-27 | 15847264.7 | 3202909 | ||
| GB | 2017-04-27 | 15847264.7 | 3202909 | ||
| FR | 2017-04-27 | 15847264.7 | 3202909 | ||
| DE | 2017-04-27 | 15847264.7 | 3202909 | ||
| US | 2017-06-02 | 15/515,266 | 10,280,420 | ||
| 8 | KR | 2011-05-26 | 10-2011-0050324 | CANCER GENE THERAPEUTIC AGENT THROUGH REGULATION USING MICRO RNA | 10-1478869 |
| 9 | KR | 2008-08-25 | 10-2008-0082732 | RECOMBINANT ADENOVIRUS COMPRISING TISSUE-SPECIFIC PROMOTER AND TUMOR-TARGETING TRANS-SPLICING RIBOZYME AND USES THEREOF | 10-1034811 |
| 10 | KR | 2022-08-05 | 10-2022-0098089 | Tumor-targeting trans-splicing ribozyme as gene therapeutic agent which combined with radiation therapy | |
| PCT | 2022-08-08 | PCT/KR2022/011774 |
- Head Office#327, Software & ICT Hall, 152, Jukjeon-ro, Suji-gu, Yongin, 16890, Korea
- TEL. 031-706-8730
- FAX. 031-8018-8734
- E_mailrznomics@rznomics.com
- Research Institute and Pangyo branch office#801(Pangyo branch office), #803(Research Institute) Innovalley Bldg. C, 253, Pangyo-ro, Bundang-gu, Seongnam, 13486, Korea
- TEL. 031-706-8730
Copyright(C) 2019 Rznomics. All Rights Reserved.
